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Summary 
Reference values of WHO 1999 manual were used for the interpretation of semen analysis 
until 2010 when new reference values were introduced which have lower cut-off compared to 
WHO 1999. Therefore, several men who previously were diagnosed abnormal based on their 
semen analysis have now become normal using new reference values. This study was 
conducted on semen analyses of 661 men from Middle East region and Pakistan. All semen 
analyses were reviewed using WHO 1999 and WHO 2010 criteria. Results showed that based 
on new criteria, 19% of the population changed classification from abnormal to normal when 
all normal semen parameters were considered. When at least one or more abnormal semen 
parameters were considered, of the total 661, 44% (288) of the population changed its 
classification from abnormal to normal with shift from WHO 1999 to 2010 criteria. These 
findings show that using new cut-off values, many more men are considered normal, but 
using old criteria (WHO 1999), the same men would be classified as abnormal. This warrants 
further discussion over the investigations and management plans for patients whose semen 
analyses fall below WHO 1999 but above WHO 2010 cut-offs. 
 
1  |  INTRODUCTION 
Semen analysis is the primary test used in the evaluation of a couple’s fertility status. The 
test is cost-effective and easy to perform. At the same time, it provides essential 
quantitative information of semen characteristics. The results of semen analysis are widely 
used to consider a male’s fertility as normal or abnormal. Therefore, most practitioners refer 
the male partner to an infertility clinic for evaluation and possible treatment merely looking 
into the semen analysis (Murray et al., 2012). In the last decade, the decision to consider a 
semen analysis report as normal or abnormal was based on the criteria set by the World Health 
Organization (WHO) using the reference values reported in the 4th edition of the manual 
(WHO, 1999) until the 5th edition was introduced in 2010 (WHO, 2010). The significance of 
this manual is that it provides universal guidelines to help the practitioner in making 
decisions to evaluate a semen analysis as normal or abnormal. This manual also provides 
step-by-step procedure how to perform a routine semen analysis along with several other 
functional tests. However, the debate over the significance of the reference values which 
distinguish the fertile man from the infertile without reinforcing the importance of the 
clinical history of the patient is of great concern (Cooper et al., 2010; De Jonge, 2012). The 
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reason for redefining the cut-off values emerged due to lack of consensus over the suitability 
of the reference values set in the 4th edition of the WHO manual. Certain fertility centres 
considered the values set for sperm concentration, motility and morphology too high,  
whereas others believed that they were too low as reviewed and commented by the authors of 
WHO 2010 manual (Cooper et al., 2010). 
 
The argument that the cut-off values are too high suggests that many fertile men would 
possibly be considered as subfertile or subnormal with regard to sperm concentration, 
motility and morphology results (Barratt, Dunphy, Thomas, & Cooke, 1988; Barratt, Naeeni, 
Clements, & Cooke, 1995; Chia, Tay, & Lim, 1998; Gao et al., 2007, 2008; Nallella, Sharma, 
Aziz, & Agarwal, 2006; Pasqualotto et al., 2006). Another major concern regarding such 
men who were considered infertile due to these high reference values was that these men 
would undergo unnecessary and expensive infertility examinations and treatments with 
assisted reproductive technologies (Cooper et al., 2010; Lemcke, Behre, & Nieschlag, 1997). 
On the other hand, the argument that these values are too low suggests that the pregnancy 
rate is directly proportionate in case the sperm concentration is between 40 and 50 × 106 
sperm/ml (Bonde et al., 1998; Slama et al., 2002) considering that a sperm concentration of 
less than 20 × 106 sperm/ml would be too low to achieve pregnancy (WHO 1987, 1992, 
1999). Further, sperm concentrations higher than the suggested cut-off of 20 × 106 sperm/ml 
were reported in infertile men (Nallella et al., 2006). 
 
In order to address this controversy of too high or too low cut-off values, new reference 
values for semen characteristics were introduced in the 5th edition of the manual (WHO, 
2010) which are lower compared to the 4th edition (WHO, 1999). Currently, almost all the 
organisations and practitioners follow the 2010 WHO reference values for semen parameters. 
 
Except for very few studies with contradictory findings, the impact of the shift from the 1999 
WHO guidelines to the 2010 guidelines on the patient referrals and the potential bias in 
counting an infertile man as fertile has not been reviewed yet. No change in the referral pattern 
was observed when the semen analyses were performed according to 2010 WHO guidelines 
(Baker, Li, & Sabanegh, 2015). However, they did report that 16% of the study population 
which was considered abnormal using WHO 1999 criteria became normal when the new 
criteria were applied. Murray et al., 2012 reported that 15% of the study population would 
be considered normal based on their semen parameters when shifting from WHO 1999 cut-
off values to WHO 2010 reference values which may result in a lesser number of men 
referred for further infertility evaluation or treatment (Murray et al., 2012). Catanzariti, 
Cantoro, Lacetera, Muzzonigro, and Polito (2013) also reported that 15.8% of the study 
population would become normal based on their semen parameters when the new reference 
values were implemented. 
 
This study is comprised of data from different countries from the Middle East and Pakistan 
and exhibit a heterogeneous representation of men. The objective was to classify the semen 
characteristics of 661 men according to WHO 1999 and 2010 reference values to analyse 
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that percentage of the population that may change classification from abnormal to normal 
using the new 2010 WHO reference values. As the population included in this study had no 
representation when the new reference values were defined, this study will add valuable 
knowledge about the impact of new reference values in the diagnostic value of semen analyses 
and possible changes in the referral pattern for subsequent male infertility assessment and 
treatment in this population. 
 
1. | MATERIALS AND METHODS 
Ethical approval was obtained from the concerned centres. Retrospective analysis of 
semen characteristics was performed from July 2011 to 2014 at four centres; Riyadh, 
Alkharj (Saudi Arabia), Cairo (Egypt) and Lahore (Pakistan). Irrespective of the female 
factor, semen results of men who had a history of more than 1 year of infertility were 
considered. Azoospermic subjects and men with more than 7 or less than 2 days of sexual 
abstinence were excluded. All men provided two semen samples within 2–3 weeks’ time. The 
underlying aetiological factor of infertility or abnormal semen analysis was not taken into 
consideration. The goal of this article was to review the semen analyses of patients which 
were assessed according to WHO 2010 criteria at different centres during 2011 and 2014. 
The same semen analyses were interpreted using old criteria (WHO 1999) aiming to see how 
new reference values can impact the interpretation of a semen analysis as new criteria have 
lower cut-off values compared to the old. Only those semen analyses were included which 
were performed by manual method. The CASA results were not available for several patients 
and were not included. The core parameters on which the analysis were classified include 
semen volume, total sperm motility, concentration and normal sperm morphology. 
 
2. |  RESULTS 
After all exclusions, a total of 661 semen analyses from multiple centres were reviewed over a 
3-year period. The WHO, 1999 and 2010 values along with per cent decline in these values 
with a shift to new criteria are given in Table 1. Overall, means (±SD) of semen volume, 
sperm concentration, motility and normal morphology of all samples were 3.1 ± 1.5 ml, 47.0 ± 
51.3 million/ml, 40 ± 20% and 11 ± 17% respectively. A comparative classification of patient’s 
semen analyses (n = 661) as normal or abnormal based on WHO 1999 and 2010 criteria is 
given in Table 2. This comparison shows that 4% of the subjects qualified as normal according 
to the WHO 1999 criteria, whereas 23% qualified as normal when the WHO 2010 reference 
values were applied. This indicates that when the overall semen parameters are taken into 
consideration, there was an increase in the number of subjects regarded as normal by 19%. 
 
Semen analyses of the study population were also categorised as normal or abnormal 
considering the individual semen characteristics using both criteria. This analysis revealed that 
of the total 661 men, 8% changed their classification as normal for the semen volume, 7% for 
sperm concentration, 20% for sperm motility and 31% for normal sperm morphology with the 
application of 2010 WHO criteria, but were abnormal when WHO 1999 criteria were applied 
(Table 3). 
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A subclassification based on the sperm parameter abnormalities (i.e., oligozoospermia, 
asthenozoospermia, teratozoospermia, oligoasthenozoospermia [OA], oligoteratozoospermia 
[OT], oligoasthenoteratozoospermia [OAT]) is depicted in Table 4. A clear shift in the 
respective total numbers of patients as well as the percentage of patients belonging to a specific 
group can be noticed from WHO 1999 to WHO 2010 criteria. Furthermore, the percentages 
of patients which are considered abnormal according to WHO 1999 but normal with regard to 
WHO 2010 were categorised. When sperm parameter abnormalities (concentration, motility, 
normal sperm morphology) were taken into consideration, either as single abnormal 
parameter or multiple abnormal parameters, of the 661 semen analyses, a total of 288 (44%) 
were below the fifth percentile of 1999 but above the fifth percentile of 2010 WHO criteria. This 
demonstrates that using 2010 criteria, 44% of the total semen analyses were regarded as 
normal, while these patients were abnormal according to 1999 WHO criteria. Of these 288 men, 
84% had single sperm parameter abnormality (oligozoospermia, asthenozoospermia or 
teratozoospermia), 6% had abnormal concentration and motility together (OA), 9% had 
abnormal concentration and morphology (OT), 34% had abnormal motility and morphology 
(asthenoteratozoospermia) and 2% had abnormal concentration, motility and morphology 
(OAT). 
 
4  |  DISCUSSION 
Cut-off values for semen analysis defined in 4th edition of WHO manual (1999) were used to 
report semen parameters as normal or abnormal until 2010 when 5th edition of the WHO 
manual was introduced. The new edition describes the procedures for the routine semen 
analysis; sperm function tests and revised quality control sections in more detail. Yet, the 
most important feature of 2010 WHO manual is the inclusion of fertile men with known time 
taken to pregnancy from different countries which was lacking in the 1999 WHO manual. In 
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order to understand these reference values and to be able to put them into context, it is 
important to note that these new reference values in the 2010 WHO manual were principally 
based on Northern European and American studies with 10% representation from Australia 
and therefore show an over-representation of certain countries such as those from Northern 
Europe (Esteves et al., 2012). Other countries Africa, Eastern Europe, Central and South 
America and Asia were under-represented (Cooper et al., 2010; Esteves et al., 2012). 
 
Previously, few studies have reported the impact of the new reference values on the evaluation 
of semen analysis and the percentage shift in the result thereof in men who were conceded 
abnormal according to the 1999 WHO guidelines, but changed their classification to normal 
when the 2010 WHO reference values were introduced (Baker et al., 2015; Catanzariti et al., 
2013; Murray et al., 2012). The present study comprises a population from Middle Eastern 
and Indo-Pakistan subcontinent regions. Millions of fertile men are living in these 
countries, and this area has a high population growth rate. Yet, this region did not contribute 
any data when reference values for the 5th edition of the WHO manual were defined. Thus, 
the aim of the present study was to analyse the change in the diagnosis and interpretation of 
semen analysis as normal or abnormal, using the 2010 WHO reference values in comparison 
to the 1999 WHO cut-off values in this population. We also wanted to know the percentage 
population which was abnormal according to WHO 1999 guidelines, but changed the 
classification to normal when WHO 2010 criteria were applied. 
 
Results showed that according to WHO 1999 criteria, 4% (28 of 661) of the patients were 
normal with respect to all parameters (volume, count, motility and normal sperm 
morphology). When the same study group was analysed against WHO 2010 reference values 
considering the same semen parameters, 23% (152/661) of the patients qualified as normal. 
These numbers show that by using the new criteria, 19% more patients are classified as 
normal who were abnormal according to the old criteria. On the other hand, when at least 
one abnormal parameter (volume, concentration, motility or normal sperm morphology) was 
considered, 44% (288 of 661) of the population fell below the fifth percentile of the 1999 
WHO cut-off values but above the fifth percentile of the 2010 WHO reference values. This 
means that according to WHO 1999, at least one sperm parameter was abnormal in these 
men, and the semen analyses were declared abnormal. However, when the new reference values 
were implemented, their abnormal status was assessed as normal. For example, if a semen 
analysis had a volume of 1.5 ml, a sperm concentration of 18 million/ml, motility of 42% and 
7% normal sperm morphology, and then according to WHO 1999, all semen parameters are 
below the cut-off values and the analysis was regarded as abnormal. 
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However, according to the 2010 WHO manual, all these parameters are above the lower 
reference values, and therefore, the analysis was regarded as normal. Likewise, another 
semen analysis with a volume of 2 ml, a sperm concentration of 16 million/ml, a motility of 
52% and 14% normal sperm morphology was declared oligozoospermic according to WHO 
1999 because only the concentration was below the cut-off value. According to WHO 2010, 
however, the same concentration is above the lower reference value and the analysis was 
regarded as normal. 
 
Most of the gynaecologist who also treat male infertility and those infertility experts who lack 
extensive training in male infertility usually ignore the total sperm count number and are 
merely looking at sperm concentration when reporting the results. However, it should be kept 
in mind that just sperm concentration should not be considered sufficient in declaring a 
semen report as normal or abnormal based on sperm number. The total sperm count is one 
of the key parameter which should also be considered. If a semen sample shows sperm 
concentration of 13 million/ml and volume of 5 ml; merely looking at concentration it will be 
regarded as oligospermia. However, based on total sperm count, it qualifies as normal 
according to both criteria (WHO 1999, 2010). 
 
The same attention must be given when looking for sperm motility results. The infertility 
practitioners lacking advanced training in andrology especially in developing countries 
http://repository.uwc.ac.za
7 
 
where much of infertility practice (males and females) is handled by gynaecologists, the main 
focus is given to total motility and progressive motility is ignored. Progressive motility is 
one of the key parameter of sperm motion, but it needs expert eye to be assessed correctly 
when using manual method. In single semen sample, the results of progressive motility 
assessed by two different observes are more variable compared to total motility. Further, the 
assessment of semen analysis by manual method is subject to observer’s experience 
particularly in case of progressive motility. In the current study, data were collected from four 
different centres therefore, chances of inter-observers variations in case of progressive 
motility were relatively higher compared to total motility. Additionally, the criteria to assess 
progressive motility in WHO 1999 and WHO 2010 differ. According to WHO 1999, 
progressive motility refers to “grade a” only and should be ≥25%, whereas in WHO 2010, it 
refers to “grades a + b” and should be 32%. Therefore, to minimise such bias, we have 
reported total motility which is the cumulative number of all grades assessed by either 
criterion (WHO 1999 or WHO 2010). Several recent key studies have also reported total 
motility instead of progressive motility (Baker et al., 2015; Catanzariti et al., 2013; Murray et 
al., 2012). 
 
Almost all the andrology and clinical laboratories dealing with infertility have switched to the 
2010 WHO reference values, and scientists and clinicians are reporting the semen analysis 
as normal or abnormal based on the new reference values. In this study, 44% of the subjects 
were regarded abnormal according to the old criteria but normal when the new criteria were 
applied. If the same study cohort was to be analysed before the implementation of WHO 
2010 values, these men would have been subjected to further fertility evaluations such as 
detailed clinical and radiographic examinations of the male reproductive tract including the 
testes and sperm function tests, that is sperm DNA fragmentation. However, as these semen 
analyses are now regarded as normal, clinicians may not ask for further male evaluation and 
would rather turn towards assisted reproductive techniques such as intrauterine insemination 
which may cause extra financial and psychological burden. 
 
Now the problem is if the semen analysis shows numbers which are abnormal according to 
WHO 1999 but normal according to WHO 2010; the person should be considered normal. 
Usually, the couples consult for fertility issues after one year or more of marriage or living 
together. The question is that after a defined period of infertility (1 year or more) if the couple 
is still unable to conceive and the semen numbers appear constantly normal what decision 
the provider will take? Will he or she go for female investigations and if found normal, will he 
or she return back towards intensive male evaluation, declare unexplained infertility, go for 
assisted reproductive treatment or do nothing? These are the questions which should be 
considered while dealing with men whom semen analyses fall in the grey zone. The couples 
with no conception after unprotected intercourse of longer than 12 months and those with 
advanced age even if no conception occurred during a period less than 12 months must be 
explored beyond semen analysis for sperm function tests (sperm DNA fragmentation, sperm 
chromatin condensation), varicocele or any other underlying aetiological factor. 
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There is well-established consensus that advanced age of women is negatively related to 
reproductive outcome. Therefore, such women are advised infertility treatment as soon as 
possible to avoid further delay. However, in couples where the male is at advanced age, the 
decision-making is not as firm as in females because of controversy in defining the threshold 
of advanced paternal age. One study (Zhu et al. (2011)) reported decline in motility and 
normal sperm morphology as from 30 years of age, while another study (Kidd, Eskenazi, & 
Wyrobek, 2001) reported decline in sperm concentration at the age of 34 years. In turn, others 
report declines in sperm motility and sperm functions such as DNA fragmentation beyond 
40 years (Marcon & Boissonneault, 2004; Singh, Muller, & Berger, 2003; Stone, Alex, 
Werlin, & Marrs, 2013). Nonetheless, advanced paternal age has shown to affect the 
reproductive outcome not only after natural conceptions but also achieved through assisted 
reproduction (Sharma et al., 2015). Therefore, this may be of concern that normal semen 
numbers based on new reference values may cause delay in procreation in couples where the 
male is at advanced age and possibility of unnecessary female examinations may increase. 
 
Despite the fact that a semen analysis can provide important information on spermatozoon, 
motility concentration and normal morphology as predictive parameters for fertilisation, it 
does not predict sperm functional defects such as DNA fragmentation, oxidative stress and 
antisperm antibodies (Agarwal, Makker, & Sharma, 2008; Bungum, Bungum, & Giwercman, 
2011). Around 30% of men with normal semen analyses diagnosed with unexplained infertility 
exhibit sperm function defects, and further investigations are warranted (Agarwal et al., 2008; 
Bungum et al., 2011). 
 
The other facet of the new reference values is how to deal patients with varicocele. Around 
15% of men from the general population suffer from varicocele, a number which ranges from 
19% to 41% in primary male infertility and 45–81% in males with secondary infertility 
(Kibar, Seckin, & Erduran, 2002). In case of abnormal semen parameters, varicocele repair is 
recommended. However, there is lack of clear consensus with regard to the improvement in 
semen characteristics after varicocele surgery (Kim et al., 2016). Nonetheless, 
varicocelectomy has shown improvement in semen characteristics in young men (≤37 years) 
compared to older men (≥37) (Kimura, Nagao, Tai, Kobayashi, & Nakajima, 2016). Surgical 
repair of the varicocele improved the spontaneous conception rate by 2.87 times compared 
to those men who were not offered any treatment either surgical or medicinal (Marmar et 
al., 2007). However, the treatment becomes a challenge in cases where the semen analysis is 
categorised as normal according to new 2010 WHO reference values, particularly for those 
men who fall into the grey zone (below fifth percentile of WHO 1999, but above fifth 
percentile of WHO 2010). Several guidelines advocate varicocelectomy when semen 
parameters are abnormal, and the varicocele is palpable. The situation becomes more complex 
where reimbursement from the health insurance companies is involved. Further, the patient 
himself will be confused when the practitioner would explain that his semen analysis is 
normal, and the improvement in semen parameters after varicocelectomy is not guaranteed. 
On the other side, using the new reference values when the initial analysis shows normal 
values (grey zone population), the probability to refer men to clinicians for further fertility 
assessment will reduce. The good numbers of semen analysis may lead to either deferment or 
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complete absence in referral pattern because a large majority of the clinicians make their 
decisions on the semen analysis results. 
 
Previous studies (Baker et al., 2015; Catanzariti et al., 2013; Murray et al., 2012) which have 
compared the impact of the new reference values on interpretation of the semen analysis 
have reported a shift of not more than 16% with the implementation of new cut-off values, 
which is discernibly lower than the one of 44% in this report. Nonetheless, this current study 
has certain limitations such as the underlying aetiology for abnormal semen parameters 
which was not taken into consideration. Ideally, there should be three semen analyses from 
each man to obtain more precise results because of the variability of the parameters in seminal 
ejaculates from same individual. 
 
5 | CONCLUSION  
In conclusion, this is the first study reporting a comparison of the evaluation of human 
semen as being “normal” according to the 1999 and 2010 WHO laboratory manual from the 
Middle East and Indo-Pakistan region. Results suggest that a reasonable percentage of men 
examined for fertility problems may be considered “normal” using the 2010 new criteria and 
may not be given attention for further evaluation. However, it should be kept in mind that 
a standard semen analysis including seminal volume, sperm concentration, motility and 
normal sperm morphology is not sufficient to predict the male fertility potential as it cannot 
provide information about physiological sperm functions. Hence, the implementation of the 
new (WHO, 2010) criteria may result in lesser numbers of men referred for further 
evaluations, and more focus would shift towards female investigations. 
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